The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2021 | Updates from the NHLBI-MDS Natural History study
In this video, Mikkael Sekeres, MD, MS, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, discusses the NHLBI-MDS Natural History Study (NCT02775383), which is a prospective study that aims to collect valuable data from patients with myelodysplastic syndromes (MDS), and build a detailed biorepository to allow for a better understanding of this disease. Dr Sekeres then draws focus on the outcomes of MDS patients in this study who contracted COVID-19, and how vaccination may impact the future of these patients. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA, 2021.
